Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Exenatide or liraglutide have a role in the treatment of T2DM as monotherapy or in addition to oral antidiabetic drugs
Since GLP-1RA therapy has been shown to reduce preference for fatty foods [26], GLP-1RA therapy might be preferred for patients who would find it difficult to avoid fatty foods under normal circumstances
IV therapy directly infuses nutrients into the bloodstream, which is more effective than oral supplements
It may be a symptom of an underlying health condition such as hypothyroidism, colorectal cancer, or bowel disease ( Constipation that passes quickly and isnt severe typically isnt a cause for concern
79 Chronic hyperglycemia activates mTORC1 and reduces mTORC2 activity 157 in islet cells, which leads to the translocation of FOXO1 to nucleus and less nuclear PDX1, resulting in reduced insulin synthesis and secretion and impaired cell mass 80,158 (Fig
when you put them together, you create a protein